{
    "clinical_study": {
        "@rank": "57009", 
        "acronym": "BOLD", 
        "brief_summary": {
            "textblock": "In this study, investigators intend to measure changes in BOLD contrast in the breast\n      induced by breath-holding for subjects receiving radiation therapy to the breast.  This\n      study will provide the preliminary data and experience needed to successfully apply BOLD to\n      quantify changes in oxygenation and blood flow of breast and tumor for a larger cohort of\n      breast radiotherapy patients.  The current study has the following objectives:\n\n        1. To determine the feasibility of BOLD contrast MRI of the breast, induced by\n           breath-hold.\n\n        2. To measure the change in BOLD contrast of the breast and / or chest wall tissue for\n           females undergoing radiotherapy"
        }, 
        "brief_title": "Feasibility of Blood Oxygenation Level-Dependent Contrast (BOLD) Breast MRI Induced by Breath- Holding", 
        "completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Breast Cancer", 
        "condition_browse": {
            "mesh_term": "Breast Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "11 subjects were consented to the trial. One subject voluntarily withdrew before any study\n      procedures were performed."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria: \u2022 Post-operative patients who are undergoing planning for future whole\n        breast radiation therapy  may be included in the study\n\n          -  Female\n\n          -  Age \u226518\n\n          -  Negative serum pregnancy test for women of child bearing potential\n\n          -  Signed study-specific informed consent\n\n        Exclusion Criteria:\n\n          -  Unable to perform breath-holding of adequate duration.\n\n          -  Unable  to lie prone for approximately one hour during the study procedure\n\n          -  Breast implants\n\n          -  Any condition for which a MRI procedure is contraindicated including presence of\n             metallic material in the body, such as pacemakers, non- MRI compatible surgical\n             clips, shrapnel, etc.\n\n          -  Positive serum pregnancy test\n\n          -  Mastectomy"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Female subjects with breast cancer"
            }
        }, 
        "enrollment": {
            "#text": "11", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01898533", 
            "org_study_id": "Pro00046072"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 14, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Durham", 
                    "country": "United States", 
                    "state": "North Carolina", 
                    "zip": "27710"
                }, 
                "name": "Duke University Medical Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "A Pilot Study of the Feasibility of Blood Oxygenation Level-Dependent Contrast ( BOLD) Breast MRI Induced by Breath- Holding", 
        "overall_official": {
            "affiliation": "Duke University", 
            "last_name": "Rachel Blitzblau, MD PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Subjects will be evaluated holding their breath and during normal breathing.", 
                "measure": "The change in BOLD contrast of the breasts and / or chest wall tissue will be measured by comparing breath hold sequences to normal breathing.", 
                "safety_issue": "No", 
                "time_frame": "During MRI approx 1 hour"
            }, 
            {
                "description": "The imaging technique will be considered feasible if for any of the proposed imaging sequences, breath-holding induces a measurable (\u22653\u00d7 standard deviation of background) BOLD contrast signal in at least 30% of the subjects. Contrast will be measured by comparing breath hold sequences  to normal breathing.", 
                "measure": "Feasibility as measured by a BOLD contrast signal in at least 30% of subjects", 
                "safety_issue": "No", 
                "time_frame": "During MRI approx one hour"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01898533"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Duke University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Duke University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}